Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Charite University, Berlin, Germany
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Samsung Medical Center
Northwestern University
Swiss Cancer Institute
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Emory University
Ruijin Hospital
The Methodist Hospital Research Institute
Singapore General Hospital
University Hospital Southampton NHS Foundation Trust
OHSU Knight Cancer Institute
Roswell Park Cancer Institute
Asan Medical Center
Jonsson Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Mayo Clinic